oral semaglutide brands Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Best Semaglutide Options for 2026:

TGA issues a separate warning for Mounjaro about risk of reduced effectiveness of contraception

A NX35 exosome systemnot a single solution

Results from a clinical trial suggest that semaglutide, the substance in Ozempic and Wegovy, can halt and even reverse a common liver disease that affects millions worldwide.

The success of GLP-1s in reducing weight has led some to predict industry-disruptive impacts for the medtech industry, as demand for medical devices and surgical procedures could be greatly reduced.

Notably, the US-FDA has approved Aducanumab and Lecanemab, both antibodies targeting amyloid, marking the end of a nearly two-decade period without new AD drugs

Pricing for compounded tirzepatide delivered via telemedicine.